Senseonics Holdings, Inc.
SENS
Positions held
Your positionsSENS isn't in your positions.
Add it to see shares, cost, and P&L here.
Fundamentals
| Market cap | $476.92M | Enterprise value | $397.08M | Trailing P/E | — | Forward P/E | -4.61 |
| PEG | — | Price / book | 5.28 | Beta | 1.03 | Dividend yield | 0.00% |
| Revenue growth | 117.8% | Earnings growth | — | Gross margin | 54.9% | Operating margin | -2.5% |
| Profit margin | -2.3% | ROE | -118.2% | ROA | -41.4% | Debt / equity | 0.70 |
| Current ratio | 6.75 | Free cash flow | -$59.24M | Analyst recommendation | buy | Mean target | $13.50 |
| 52w high | $10.64 | 52w low | $4.79 |
Quarterly
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | |
|---|---|---|---|---|---|---|
| Revenue | $14.5M | $11.7M | $14.3M | $8.1M | $6.6M | — |
| Op margin | -248.5% | -271.9% | -146.8% | -242.1% | -215.4% | — |
| Net income | -$36.7M | -$32.3M | -$20.8M | -$19.5M | -$14.5M | — |
| Gross margin | 59.1% | 59.3% | 53.8% | 42.8% | 46.9% | — |
| Gross profit | $8.6M | $6.9M | $7.7M | $3.5M | $3.1M | — |
| Operating income | -$36.0M | -$31.8M | -$20.9M | -$19.6M | -$14.3M | — |
- Revenue +24% vs prior quarter ($14M vs $12M).
- Gross margin 59.1% (was 59.3% prior quarter).
- Operating margin expanded to -248.5%.
Yearly (6y)
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | $35.3M | $22.5M | $22.4M | $16.4M | — |
| Op margin | -193.8% | -333.0% | -337.7% | -418.7% | — |
| Net income | -$69.1M | -$78.6M | -$60.4M | $142M | — |
| Gross margin | 44.7% | 2.4% | 13.8% | 16.6% | — |
| Gross profit | $15.8M | $0.5M | $3.1M | $2.7M | — |
| Operating income | -$68.3M | -$74.8M | -$75.6M | -$68.6M | — |
No flags
• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).
News
2026-10-07 · Flutter upgraded, AppFolio downgraded: Wall Street's top analyst calls
2026-09-29 · Beta Bionics Stock Down Despite iLet-Eversense 365 Integration Deal
2026-09-22 · Beta Bionics, Senseonics Partner to Integrate Diabetes Devices
2026-09-14 · Senseonics, Beta Bionics Partner on Eversense 365-iLet Diabetes System
2026-09-10 · Senseonics To Participate in Upcoming Institutional Investor Conferences
2026-08-25 · Sensirion Holding AG (XSWX:SENS) (H1 2026) Earnings Call Highlights: Broad-Based Growth and ...
2026-08-12 · Is DXCM Stock Worth Buying as Growth Improves but Valuation Stretches?
2026-08-07 · Senseonics Holdings, Inc. Common Stock Q2 Earnings Call Highlights
2026-08-07 · Senseonics Holdings Inc (SENS) (Q2 2026) Earnings Call Highlights: Revenue Soars 120% as ...
2026-08-06 · Senseonics Holdings (SENS) Reports Q2 Loss, Tops Revenue Estimates
2026-08-06 · Senseonics: Q2 Earnings Snapshot
Price (daily)
Full chart · RSI · MACD · patterns